Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Melanoma | 36 | 2022 | 5692 | 2.860 |
Why?
|
Sentinel Lymph Node Biopsy | 12 | 2021 | 726 | 2.290 |
Why?
|
Skin Neoplasms | 31 | 2021 | 5796 | 2.130 |
Why?
|
Lymph Node Excision | 12 | 2021 | 1304 | 1.150 |
Why?
|
Lymph Nodes | 8 | 2019 | 3489 | 1.120 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 7 | 2020 | 92 | 0.960 |
Why?
|
Lymphatic Metastasis | 15 | 2019 | 2943 | 0.690 |
Why?
|
Inguinal Canal | 1 | 2019 | 72 | 0.680 |
Why?
|
Leiomyosarcoma | 2 | 2020 | 424 | 0.640 |
Why?
|
Ilium | 1 | 2019 | 154 | 0.640 |
Why?
|
Retroperitoneal Neoplasms | 2 | 2024 | 329 | 0.640 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2020 | 1788 | 0.560 |
Why?
|
Neoplasm Recurrence, Local | 12 | 2020 | 9269 | 0.500 |
Why?
|
Australia | 12 | 2021 | 1287 | 0.500 |
Why?
|
Neoplasms, Second Primary | 2 | 2022 | 1058 | 0.480 |
Why?
|
Breast Neoplasms | 23 | 2020 | 21022 | 0.440 |
Why?
|
Preoperative Care | 2 | 2024 | 2256 | 0.430 |
Why?
|
Neoplasm Staging | 19 | 2021 | 11123 | 0.390 |
Why?
|
Acetone | 1 | 2011 | 44 | 0.390 |
Why?
|
Head and Neck Neoplasms | 4 | 2020 | 2876 | 0.380 |
Why?
|
Methanol | 1 | 2011 | 91 | 0.370 |
Why?
|
Melanocytes | 1 | 2014 | 511 | 0.370 |
Why?
|
Sarcoma | 2 | 2024 | 1786 | 0.370 |
Why?
|
Groin | 1 | 2011 | 106 | 0.370 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 1627 | 0.360 |
Why?
|
Mammography | 5 | 2018 | 2449 | 0.350 |
Why?
|
Quality of Life | 4 | 2019 | 13284 | 0.340 |
Why?
|
Melphalan | 6 | 2020 | 421 | 0.310 |
Why?
|
Soft Tissue Neoplasms | 1 | 2017 | 1151 | 0.310 |
Why?
|
Titanium | 1 | 2011 | 484 | 0.310 |
Why?
|
Skin | 3 | 2020 | 4467 | 0.310 |
Why?
|
Precancerous Conditions | 1 | 2014 | 979 | 0.290 |
Why?
|
Surgical Flaps | 2 | 2018 | 1666 | 0.290 |
Why?
|
Prognosis | 18 | 2024 | 29561 | 0.290 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 881 | 0.280 |
Why?
|
Patient Care | 1 | 2012 | 624 | 0.260 |
Why?
|
Survival Rate | 9 | 2020 | 12800 | 0.250 |
Why?
|
Risk Assessment | 5 | 2016 | 24049 | 0.250 |
Why?
|
Breast | 4 | 2018 | 1979 | 0.250 |
Why?
|
Extremities | 3 | 2020 | 864 | 0.250 |
Why?
|
Water | 1 | 2011 | 1401 | 0.240 |
Why?
|
Immunologic Factors | 1 | 2014 | 1588 | 0.240 |
Why?
|
Neoplastic Stem Cells | 2 | 2016 | 1344 | 0.240 |
Why?
|
Neoplasm Invasiveness | 10 | 2019 | 3619 | 0.240 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2006 | 327 | 0.240 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2803 | 0.230 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2020 | 549 | 0.230 |
Why?
|
Carcinoma in Situ | 2 | 2006 | 796 | 0.230 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39216 | 0.210 |
Why?
|
Lower Extremity | 4 | 2020 | 1194 | 0.210 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2006 | 1093 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2020 | 11653 | 0.200 |
Why?
|
Aged, 80 and over | 22 | 2020 | 58867 | 0.200 |
Why?
|
Lymphedema | 2 | 2019 | 525 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5635 | 0.190 |
Why?
|
Mastectomy | 2 | 2006 | 1834 | 0.190 |
Why?
|
Radiotherapy | 2 | 2020 | 1503 | 0.190 |
Why?
|
Humans | 69 | 2024 | 759255 | 0.190 |
Why?
|
Aged | 32 | 2024 | 168617 | 0.180 |
Why?
|
Middle Aged | 38 | 2024 | 219653 | 0.180 |
Why?
|
Upper Extremity | 3 | 2020 | 656 | 0.170 |
Why?
|
Subcutaneous Tissue | 1 | 2020 | 132 | 0.170 |
Why?
|
Female | 50 | 2024 | 390240 | 0.170 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7460 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2021 | 2052 | 0.160 |
Why?
|
Dactinomycin | 4 | 2020 | 303 | 0.160 |
Why?
|
Kaplan-Meier Estimate | 4 | 2018 | 6532 | 0.150 |
Why?
|
Lung Neoplasms | 2 | 2020 | 13238 | 0.150 |
Why?
|
Propranolol | 1 | 2019 | 489 | 0.150 |
Why?
|
Indoles | 2 | 2017 | 1828 | 0.150 |
Why?
|
Neoplasm Metastasis | 7 | 2020 | 4883 | 0.150 |
Why?
|
Biopsy, Fine-Needle | 2 | 2020 | 1111 | 0.150 |
Why?
|
Mammary Glands, Human | 2 | 2016 | 204 | 0.140 |
Why?
|
Phlebotomy | 1 | 2018 | 137 | 0.140 |
Why?
|
Adult | 31 | 2024 | 219390 | 0.140 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2019 | 619 | 0.140 |
Why?
|
Stromal Cells | 2 | 2015 | 1327 | 0.140 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2017 | 937 | 0.140 |
Why?
|
Manikins | 1 | 2018 | 242 | 0.140 |
Why?
|
Punctures | 1 | 2018 | 368 | 0.140 |
Why?
|
Quality Improvement | 1 | 2012 | 3836 | 0.140 |
Why?
|
Collagenases | 1 | 2016 | 220 | 0.130 |
Why?
|
Male | 29 | 2024 | 358719 | 0.130 |
Why?
|
Rose Bengal | 1 | 2016 | 115 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13621 | 0.130 |
Why?
|
Epithelium | 3 | 2018 | 1605 | 0.130 |
Why?
|
Scalp | 1 | 2018 | 389 | 0.120 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2016 | 198 | 0.120 |
Why?
|
Retrospective Studies | 14 | 2022 | 80121 | 0.120 |
Why?
|
Immunohistochemistry | 8 | 2021 | 11058 | 0.120 |
Why?
|
Liposarcoma | 1 | 2017 | 283 | 0.120 |
Why?
|
Disease Management | 3 | 2021 | 2498 | 0.120 |
Why?
|
Hydroxamic Acids | 1 | 2017 | 482 | 0.110 |
Why?
|
Morbidity | 1 | 2019 | 1764 | 0.110 |
Why?
|
Necrosis | 1 | 2018 | 1613 | 0.110 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 4573 | 0.110 |
Why?
|
Neck Dissection | 1 | 2014 | 200 | 0.110 |
Why?
|
Skin Transplantation | 1 | 2018 | 1082 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2824 | 0.100 |
Why?
|
Axilla | 3 | 2010 | 617 | 0.100 |
Why?
|
Pilot Projects | 3 | 2024 | 8540 | 0.100 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 772 | 0.100 |
Why?
|
Prospective Studies | 10 | 2019 | 54204 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 934 | 0.100 |
Why?
|
Survival Analysis | 6 | 2020 | 10185 | 0.100 |
Why?
|
Hospital Information Systems | 1 | 2013 | 396 | 0.090 |
Why?
|
New Zealand | 1 | 2012 | 354 | 0.090 |
Why?
|
Adsorption | 1 | 2011 | 197 | 0.090 |
Why?
|
Monosaccharide Transport Proteins | 2 | 2003 | 440 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 1 | 2024 | 4040 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12964 | 0.090 |
Why?
|
Organoids | 1 | 2016 | 729 | 0.090 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6813 | 0.090 |
Why?
|
Immunomodulation | 1 | 2014 | 547 | 0.090 |
Why?
|
Carcinoma, Ductal | 1 | 2010 | 98 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2018 | 5194 | 0.080 |
Why?
|
Receptor, erbB-2 | 2 | 2017 | 2524 | 0.080 |
Why?
|
Biopsy | 2 | 2019 | 6772 | 0.080 |
Why?
|
Medical Order Entry Systems | 1 | 2013 | 522 | 0.080 |
Why?
|
Surface Properties | 1 | 2011 | 1158 | 0.080 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1914 | 0.080 |
Why?
|
Immunotherapy | 2 | 2019 | 4622 | 0.080 |
Why?
|
Dermatology | 1 | 2018 | 912 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2012 | 509 | 0.070 |
Why?
|
Medication Errors | 1 | 2013 | 781 | 0.070 |
Why?
|
Caveolin 1 | 1 | 2009 | 257 | 0.070 |
Why?
|
Cause of Death | 1 | 2018 | 3721 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2020 | 2329 | 0.070 |
Why?
|
Collagen | 1 | 2015 | 2635 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1866 | 0.070 |
Why?
|
Neoadjuvant Therapy | 1 | 2017 | 2809 | 0.070 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 490 | 0.070 |
Why?
|
Phenotype | 3 | 2019 | 16532 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2353 | 0.070 |
Why?
|
Sulfonamides | 1 | 2015 | 1972 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2022 | 21988 | 0.060 |
Why?
|
Mastectomy, Segmental | 1 | 2010 | 965 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 3046 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18394 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2020 | 64879 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2020 | 4025 | 0.060 |
Why?
|
Microarray Analysis | 1 | 2007 | 748 | 0.060 |
Why?
|
RNA, Neoplasm | 2 | 2004 | 748 | 0.060 |
Why?
|
Guidelines as Topic | 2 | 2021 | 1395 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2016 | 4409 | 0.050 |
Why?
|
Recurrence | 1 | 2015 | 8469 | 0.050 |
Why?
|
Sialoglycoproteins | 1 | 2004 | 315 | 0.050 |
Why?
|
Length of Stay | 2 | 2020 | 6452 | 0.050 |
Why?
|
Young Adult | 7 | 2020 | 58483 | 0.050 |
Why?
|
Chromosomes, Human, Pair 8 | 1 | 2004 | 452 | 0.050 |
Why?
|
Risk Factors | 5 | 2019 | 74167 | 0.050 |
Why?
|
Cell Division | 2 | 2007 | 4463 | 0.050 |
Why?
|
Gene Dosage | 2 | 2004 | 1218 | 0.050 |
Why?
|
Tumor Cells, Cultured | 5 | 2016 | 6131 | 0.050 |
Why?
|
Cohort Studies | 7 | 2020 | 41247 | 0.050 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2003 | 419 | 0.050 |
Why?
|
Mice, SCID | 2 | 2016 | 2628 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20461 | 0.050 |
Why?
|
RNA, Messenger | 5 | 2016 | 12774 | 0.050 |
Why?
|
Interferon-alpha | 1 | 2004 | 918 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2004 | 1056 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2004 | 1387 | 0.040 |
Why?
|
Tourniquets | 1 | 2020 | 110 | 0.040 |
Why?
|
Receptors, Estrogen | 2 | 2009 | 2201 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10747 | 0.040 |
Why?
|
Urban Population | 1 | 2006 | 2015 | 0.040 |
Why?
|
International Agencies | 1 | 2019 | 244 | 0.040 |
Why?
|
National Health Programs | 1 | 2021 | 442 | 0.040 |
Why?
|
Creatine Kinase | 1 | 2020 | 691 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3584 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21336 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2003 | 3774 | 0.040 |
Why?
|
Mass Screening | 2 | 2019 | 5419 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2014 | 9194 | 0.040 |
Why?
|
Extracorporeal Circulation | 1 | 2017 | 182 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2017 | 10440 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2002 | 1152 | 0.030 |
Why?
|
Comorbidity | 1 | 2011 | 10547 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2013 | 4737 | 0.030 |
Why?
|
Rural Population | 1 | 2006 | 2260 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15672 | 0.030 |
Why?
|
Skin Ulcer | 1 | 2017 | 129 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2016 | 277 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1520 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 674 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1007 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 779 | 0.030 |
Why?
|
Estradiol | 1 | 2002 | 1932 | 0.030 |
Why?
|
Glycoproteins | 1 | 2002 | 2203 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3525 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1886 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2020 | 1265 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2006 | 2532 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2018 | 797 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2388 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4111 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2016 | 424 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1755 | 0.030 |
Why?
|
Glucose Transport Proteins, Facilitative | 2 | 2003 | 57 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1114 | 0.030 |
Why?
|
Lymphatic Vessels | 1 | 2017 | 358 | 0.030 |
Why?
|
Queensland | 1 | 2012 | 53 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1503 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10827 | 0.030 |
Why?
|
Macrophages | 2 | 2018 | 5730 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1836 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2018 | 1146 | 0.020 |
Why?
|
Mitosis | 1 | 2017 | 1195 | 0.020 |
Why?
|
Ischemia | 1 | 2020 | 1893 | 0.020 |
Why?
|
Blood Vessels | 1 | 2017 | 1112 | 0.020 |
Why?
|
United States | 4 | 2020 | 72237 | 0.020 |
Why?
|
Animals | 6 | 2017 | 167838 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 729 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1870 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2017 | 16871 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1375 | 0.020 |
Why?
|
Mice | 5 | 2017 | 81138 | 0.020 |
Why?
|
Immunosorbent Techniques | 1 | 2009 | 176 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2010 | 516 | 0.020 |
Why?
|
Trust | 1 | 2013 | 523 | 0.020 |
Why?
|
Blotting, Western | 1 | 2016 | 5039 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1574 | 0.020 |
Why?
|
Commerce | 1 | 2013 | 604 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2448 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2017 | 2198 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2004 | 2499 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 41935 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2018 | 2725 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15264 | 0.020 |
Why?
|
Victoria | 1 | 2006 | 64 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9374 | 0.020 |
Why?
|
Cell Survival | 1 | 2017 | 5796 | 0.020 |
Why?
|
Medical Informatics | 1 | 2013 | 732 | 0.020 |
Why?
|
Child | 3 | 2020 | 79623 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10518 | 0.020 |
Why?
|
Magnetics | 1 | 2009 | 600 | 0.020 |
Why?
|
Microspheres | 1 | 2009 | 786 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4545 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5870 | 0.020 |
Why?
|
Receptors, Virus | 1 | 2009 | 639 | 0.020 |
Why?
|
Mutation | 2 | 2021 | 29877 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8055 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 87560 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4733 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40109 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2017 | 2250 | 0.010 |
Why?
|
Integrin-Binding Sialoprotein | 1 | 2004 | 23 | 0.010 |
Why?
|
Data Collection | 1 | 2013 | 3317 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 2009 | 1122 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1724 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8929 | 0.010 |
Why?
|
Paraffin Embedding | 1 | 2003 | 302 | 0.010 |
Why?
|
Sequence Homology | 1 | 2002 | 195 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 240 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2003 | 1304 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2007 | 1060 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2002 | 1544 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9492 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20031 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2004 | 2015 | 0.010 |
Why?
|
Neck | 1 | 2004 | 730 | 0.010 |
Why?
|
Introns | 1 | 2002 | 976 | 0.010 |
Why?
|
Gene Library | 1 | 2002 | 1060 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1633 | 0.010 |
Why?
|
Immunoblotting | 1 | 2002 | 1649 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12152 | 0.010 |
Why?
|
Biological Transport | 1 | 2003 | 2086 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 1993 | 0.010 |
Why?
|
Gene Amplification | 1 | 2003 | 1085 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35941 | 0.010 |
Why?
|
Brain Chemistry | 1 | 2002 | 959 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25860 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18110 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2002 | 2474 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12522 | 0.010 |
Why?
|
Mice, Nude | 1 | 2004 | 3605 | 0.010 |
Why?
|
Models, Animal | 1 | 2004 | 2118 | 0.010 |
Why?
|
Oncogenes | 1 | 2003 | 1221 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1953 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4918 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9528 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2002 | 4171 | 0.010 |
Why?
|
Menopause | 1 | 2004 | 1640 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2002 | 1666 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2389 | 0.010 |
Why?
|
Transfection | 1 | 2004 | 5783 | 0.010 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2003 | 938 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6218 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2009 | 3204 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2003 | 4625 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2002 | 1655 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2004 | 6542 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2004 | 6070 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2009 | 14381 | 0.010 |
Why?
|
Signal Transduction | 1 | 2017 | 23362 | 0.010 |
Why?
|
Cell Membrane | 1 | 2002 | 3683 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2002 | 2804 | 0.010 |
Why?
|
Registries | 1 | 2007 | 8434 | 0.010 |
Why?
|
Glucose | 1 | 2003 | 4361 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13456 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17629 | 0.010 |
Why?
|
Insulin | 1 | 2002 | 6591 | 0.000 |
Why?
|
Proteins | 1 | 2002 | 6029 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2003 | 8491 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2002 | 26109 | 0.000 |
Why?
|
Pregnancy | 1 | 2002 | 29658 | 0.000 |
Why?
|